Table 1. Baseline and clinical characteristics of all the lung cancer patients.
| All Lung cancerpatients, N=178 | Early stage (I-IIIA),Lung AC patients,N=24 | Advanced stage(IIIB-IV), Lung ACpatients, N = 91 | P value* | |
|---|---|---|---|---|
| Age, years | 66.7±8.3 | 63.8±12 | 0.268 | |
| Male, n (%) | 115 (64.6) | 11 (45.8) | 49 (53.8) | 0.48 |
| Smoking history, n (%) | 57 (34) | 5 (20.9) | 24 (26.4) | 0.426 |
| TNM stage, n (%) | ||||
| T1 | 15 (8.4) | 5 (20.8) | 5 (5.5) | <0.001 |
| T2 | 67 (37.6) | 16 (66.7) | 31 (34.1) | |
| T3 | 17 (9.6) | 1 (4.2) | 8 (8.8) | |
| T4 | 79 (44.4) | 2 (8.3) | 47 (51.6) | |
| N0 | 33 (18.5) | 14 (58.3) | 10 (11) | <0.001 |
| N1 | 23 (12.9) | 1 (4.2) | 15 (16.5) | |
| N2 | 74 (41.6) | 9 (37.5) | 37 (40.7) | |
| N3 | 48 (27) | 0 (0) | 29 (31.9) | |
| M0 | 62 (35) | 24 (100) | 14 (15.38) | <0.001 |
| M1 | 116 (65) | 0 (0) | 77 (84.6) | |
| ECOG PS | 0.003 | |||
| 0 | 36 (20.2) | 11 (45.8) | 14 (15.4) | |
| 1 | 85 (47.8) | 11 (45.8) | 45 (49.5) | |
| 2 | 27 (15.2) | 0 (0) | 18 (19.8) | |
| 3 | 13 (7.3) | 2 (8.3) | 4 (4.4) | |
| 4 | 17 (9.6) | 0 (0) | 10 (11) |
AC = adenocarcinoma; PS = performance status
*Compared between early stage and advanced stage lung AC patients